Found: 16
Select item for more details and to access through your institution.
Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.
- Published in:
- Journal of Neurogastroenterology & Motility, 2017, v. 23, n. 2, p. 171, doi. 10.5056/jnm16183
- By:
- Publication type:
- Article
Synthesis and evaluation of anti-inflammatory properties of silver nanoparticle suspensions in experimental colitis in mice.
- Published in:
- Chemical Biology & Drug Design, 2017, v. 89, n. 4, p. 538, doi. 10.1111/cbdd.12876
- By:
- Publication type:
- Article
Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 23, p. 5660, doi. 10.3390/jcm10235660
- By:
- Publication type:
- Article
Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study.
- Published in:
- Advances in Clinical & Experimental Medicine, 2024, v. 33, n. 1, p. 69, doi. 10.17219/acem/162969
- By:
- Publication type:
- Article
Measurement of Silver Nanolayer Absorption by the Body in an in Vivo Model of Inflammatory Gastrointestinal Diseases.
- Published in:
- Metrology & Measurement Systems, 2016, v. 23, n. 1, p. 133, doi. 10.1515/mms-2016-0008
- By:
- Publication type:
- Article
Scoring system assessing mucosal visibility of upper gastrointestinal tract: The POLPREP scale.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 1, p. 164, doi. 10.1111/jgh.15662
- By:
- Publication type:
- Article
Chinese Herbal Medicines in the Treatment of IBD and Colorectal Cancer: A Review.
- Published in:
- Current Treatment Options in Oncology, 2014, v. 15, n. 3, p. 405, doi. 10.1007/s11864-014-0288-2
- By:
- Publication type:
- Article
Czynniki genetyczne w patogenezie, przebiegu i leczeniu nieswoistych chorób zapalnych jelit.
- Published in:
- Advances in Hygiene & Experimental Medicine / Postepy Higieny i Medycyny Doswiadczalnej, 2015, v. 69, p. 335
- By:
- Publication type:
- Article
Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, v. 392, n. 11, p. 1321, doi. 10.1007/s00210-019-01698-z
- By:
- Publication type:
- Article
Experimental colitis in mice is attenuated by topical administration of chlorogenic acid.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2015, v. 388, n. 6, p. 643, doi. 10.1007/s00210-015-1110-9
- By:
- Publication type:
- Article
AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice.
- Published in:
- Molecules, 2021, v. 26, n. 10, p. 2946, doi. 10.3390/molecules26102946
- By:
- Publication type:
- Article
Comparison of ustekinumab, infliximab and combination therapy in moderately to severely active ulcerative colitis - a study protocol of a randomized, multicenter, head-to-head COMBO-UC trial.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1458998
- By:
- Publication type:
- Article
Dietary Interventions in Inflammatory Bowel Disease.
- Published in:
- Nutrients, 2022, v. 14, n. 20, p. 4261, doi. 10.3390/nu14204261
- By:
- Publication type:
- Article
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, p. 1, doi. 10.1177/17562848231151295
- By:
- Publication type:
- Article
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2023, v. 16, p. 1, doi. 10.1177/17562848231151295
- By:
- Publication type:
- Article
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study).
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211036456
- By:
- Publication type:
- Article